Drug Trial Radar · NCT02814097
A Study to Evaluate the Effects of 4 Weeks Treatment With Subcutaneous Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Preserved Ejection Fraction
Last checked: Nov 20, 2026Latest source record: Sep 7, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
46
Actual
Start
Sep 2, 2016
Primary completion
May 4, 2017
Study completion Jun 2, 2017
Sponsor
- Lead sponsor
- Stealth BioTherapeutics Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Charite University, Berlin, Germany; SCIRENT Clinical Research and Science d.o.o.
- First posted
- Jun 27, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multi-center, randomized, double-blind, placebo-controlled study in subjects with stable heart failure with preserved ejection fraction (HFpEF) to evaluate the effects of 4 weeks treatment with subcutaneous MTP-131 (elampretide) on left ventricular function.
Conditions
- Chronic Heart Failure
Interventions
elamipretideDrug
Subcutaneous injection of 40 mg elamipretide once daily for 28 consecutive days
PlaceboDrug
Subcutaneous injection of placebo administered once daily for 28 consecutive days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Compare the delta in E/e' at rest exercise measured with echocardiography between the elamipretide and placebo groupsTime frame: 4 weeks
Locations
9 sites in 2 countries. Site status is shown where the registry gives one.
Charite Universitatsmedizin Berlin, Campus Virchow-Klinikum
Berlin, Germany
German Heart Center
Berlin, Germany
Clinical Centre of Serbia, Clinic for Cardiology
Belgrade, Serbia
Clinical Hospital Center "Dr Dragiša Mišović-Dedinje", Department of Cardiology
Belgrade, Serbia
Clinical Hospital Center "Zvezdara", Department of Cardiology
Belgrade, Serbia
Clinical Hospital Center "Bežanijska Kosa", Department of Cardiology
Belgrade, Serbia
Clinical Hospital Center "Zemun", Department of Cardiology
Belgrade, Serbia
Institute for Cardiovascular Diseases Vojvodina, Clinic for Cardiology
Kamenitz, Serbia
Clinical Center Niš, Clinic for Cardiology
Niš, Serbia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.